| Literature DB >> 21197455 |
A García-Peiró1, M Oliver-Bonet, J Navarro, C Abad, M Guitart, M J Amengual, J Benet.
Abstract
Although several reports on male infertility suggest a relationship between chromosome 9 polymorphisms and infertility, the effects on the phenotype have not been extensively reported. In this study, an infertile patient was found to carry a 9qh+++ chromosome. The flow cytometric TUNEL assay and SCD test have been applied to characterize sperm DNA integrity. In order to assess its meiotic behaviour, synapsis, recombination, and aneuploidy, analyses have been also performed. Sperm DNA fragmentation (SDF) was 77.81% and 87% for the TUNEL and SCD tests, respectively. Ninety-two percent of pachytene cells analyzed showed meiotic abnormalities. The mean number of MLH1 foci per pachytene in the control group was higher (49) than the mean found in the 9qh+++ patient (38) (P < .0001). In spermatozoa, significant increases of disomy rates were observed for chromosome 18 and for the sex chromosomes (P < .0001). These disturbances could be present in other male carriers of a less marked 9qh+.Entities:
Mesh:
Substances:
Year: 2010 PMID: 21197455 PMCID: PMC3004426 DOI: 10.1155/2011/730847
Source DB: PubMed Journal: J Biomed Biotechnol ISSN: 1110-7243
Figure 1Karyotype analysis shows a 9qh+++ heterozygous state. (a) G-banding of homologous 9 chromosomes. Abnormal chromosome 9 (right) showing an increased length in the q arm compared to its homologous chromosome (left). Horizontal line indicates centromere position. (b) C-banding shows an increase in the heterochromatin region of chromosome 9. Horizontal lines set the limits of the qh region.
Figure 2Cytogram for TUNEL. (a, d) The negative control was incubated without the TdT enzyme. (b, e) Positive control was prepared before the labeling reaction with an additional treatment with DNAse I. (c, f) The TUNEL-positive cell in the fertile donor and patient sample was measured, respectively, with respect to the negative-control sperm population using a 530 nm ± 30 nm band-pass filter. A total of 10 000 events were measured at a flow rate of 200–300 cells/s on a flow cytometer.
Percentages of sperm with DNA fragmentation in semen of a heterochromatin polymorphism carrier and control group of fertile donors.
| Patient | Control ( | ||
|---|---|---|---|
| TUNELa | 77.81% | 15.6% | |
| SCDb | 87% | 10.33% |
a,bFor the 9qh+++ carrier, 10000 and 300 spermatozoa were analyzed for TUNEL and SCD, respectively. For controls, 30000 and 900 sperm cells were analyzed.
Figure 3Immunolabeled pachytene cells with synaptonemal complexes. (a) Representative image from the control group showing the normal morphology of the synaptonemal complex and sex body (SB). (b) Representative image of the cytological analysis of the patient's cells. Arrowheads indicate multiple asynaptic regions in the autosomal synaptonemal complex; an asterisk indicates a loop of asynapsis as a consequence of pericentromeric heterochromatin polymorphism of chromosome 9. SCP1 and SCP3 indicate synaptonemal complexes in red; CENP indicates centromere in blue, and MLH1 (mut L homolog 1) indicates recombination foci in green.
Values obtained for asynapsis in pachytene cells in the heterochromatin polymorphism carrier.
| Normal | Anomalous | |||
|---|---|---|---|---|
| Synapsisa | 8% | 92% | ||
| Only in chromosome 9 | Chromosome 9 and others | Only in others | ||
| 40% | 32% | 20% | ||
aThe presence of synaptonemal complex abnormalities was analyzed in 50 pachytene cells.
Figure 4Images show pachytene cells with the bivalent 9 synaptonemal complex identified by FISH analysis. (a) Representative image from a control donor. (b) Representative image from the 9qh+++ patient. An asterisk indicates the loop in the pericentromeric region; SCP1 and SCP3 indicate synaptonemal complexes in red; CENP indicates centromere in blue, and chromosome enumeration probe 9 (CEP9) indicates bivalent 9 in green.
Number and percentage of asynapsis and heterosynapsis found according to the different pachytene stages analyzed for bivalent 9.
| Stage | Controla ( | Patient 9qh+++ ( | ||||
|---|---|---|---|---|---|---|
| Asynapsis in 9q | Asynapsis in 9q | Heterosynapsis in 9q | ||||
| % | % | % | ||||
| Early | 30 | 14.1 | 11 | 22 | 3 | 6 |
| Late | 13 | 6.1 | 20 | 40 | 7 | 14 |
| Unknown | — | — | 5 | 10 | 4 | 8 |
| Total (%) | 20.2 | 72 | 28 | |||
aCodina-Pascual el al., [4]
Aneuploidy percentages of chromosomes X, Y, and 18 in the heterochromatin polymorphism carrier and in a chromosomally normal control group.
| Patienta | Controlb | ||
|---|---|---|---|
| X,X | 1.3% | 0.04–0.09% | <0.0001** |
| Y,Y | 1.1% | 0.06–0.14% | <0.0001** |
| X,Y | 1.4% | 0.14–0.32% | <0.0001** |
| 18,18 | 0.9% | 0.09–0.17% | <0.0001** |
| Diploidy | 2.6% | 0.15–0.31% | <0.0001** |
a,b616 and 31134 spermatozoa were analyzed, respectively.